Lollipop‐Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long‐Term, and NIR‐Defined Glaucoma Treatment

Abstract

Glaucoma is an ophthalmic disease that is characterized by elevated intraocular pressure (IOP). Eye drops are the preferred choice to reduce IOP for the treatment of glaucoma. However, the bioavailability of eye drops is low (<5%). Their long‐term frequent administration cannot ensure patient compliance, which is the main reason for treatment failure. Inspired by lollipop, herein, a multilayered sodium alginate‐chitosan (SA‐CS) hydrogel ball (HB) decorated by zinc oxide‐modified biochar (ZnO‐BC) is developed as a new drug delivery system. The multilayer structure encapsulate timolol maleate (TM) and levofloxacin inside the different layers to realize the sustained release of drugs, which can control ocular hypertension and prevent infection effectively. The results show that the release of TM can be sustained in vitro for longer than 2 weeks. Moreover, IOP is also effectively reduced in vivo. Meanwhile, the photothermal conversion activity of ZnO‐BC can regulate drug release on demand after stimulation by near‐infrared irradiation. More importantly, the designed HB also shows good biocompatibility and antibacterial properties in vitro and in vivo. In summary, ZnO‐BC‐SA‐CS HB can effectively reduce IOP and is expected to replace the classical tedious eye drop strategy, having potential utilization value in the treatment of glaucoma.

Tubular chitosan hydrogels with a tuneable lamellar structure programmed by electrical signals

“…It is noted that the tensile strength of traditional chitosan hydrogel formed by base neutralization is in the range of 0.1–1.25 MPa. 21–23 We also found that prolonging the deposition time from 1 to 3 h increased the toughness of the hydrogel tubes. As shown in Fig.…”

Mussel-Inspired Microgel Encapsulated NLRP3 Inhibitor as a Synergistic Strategy Against Dry Eye

“…Thus, in this work, the polydopamine-based microgels are expected to improve the drug bioavailability by improving ocular surface adhesion and retention. Accordingly, undesired side effects of MCC950 can be avoided by reducing the dosage ( Wang F. et al, 2021 ). Herein, the ocular surface retention was evaluated by detecting the concentration of FS in tear samples after topical treatment.…”

Photothermal nanohybrid hydrogels for biomedical applications

“…Although there are many drugs for relieving or treating eye in drops, powders and ointments on the market, there are many deficiencies in their use, such as low permeability, low bioavailability, short stay time, frequent administration, etc. The intraocular bioavailability of these drugs is very low, usually only 1–5% ( Wang F. et al, 2021 ). At present, some non-traditional ocular drug delivery systems have been extensively studied, such as nano carriers, hydrogels, liposomes, etc.…”